共 50 条
- [6] Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial LANCET NEUROLOGY, 2018, 17 (01): : 35 - 46
- [8] Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled (vol 17, pg 35, 2018) LANCET NEUROLOGY, 2018, 17 (08): : 661 - 661